-

Masimo to Host Investor Day on December 3, 2025

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced it will host a meeting with the analyst and investor community at 9:00am PT on Wednesday, December 3, 2025.

Presentations will be led by select members of the Executive Leadership Team and will cover an overview of the company’s business, market opportunities, innovation pipeline, commercial growth strategy, and long-term financial outlook.

The company invites investors to join the event via live webcast, which will be available on the Investor Relations section of its website at https://investor.masimo.com/ under “Events and Presentations” or directly by visiting the following link: Masimo Investor Day webcast. A replay of the webcast and the related slide presentations will be available on the company’s website following the event. In-person attendance is by invitation only and registration will be required.

@Masimo | #Masimo

About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, automation and connectivity solutions. Our mission is for Masimo innovations to empower clinicians to transform patient care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature. Masimo SET® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com.

Contacts

Investor Contact:
Eli Kammerman
(949) 297-7077
ekammerman@masimo.com

Media Contact:
Evan Lamb
949-396-3376
elamb@masimo.com

Masimo

NASDAQ:MASI

Release Versions

Contacts

Investor Contact:
Eli Kammerman
(949) 297-7077
ekammerman@masimo.com

Media Contact:
Evan Lamb
949-396-3376
elamb@masimo.com

More News From Masimo

Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which confirmed the validity of Masimo Patent No. 10,433,776, found Apple infringed this patent, and awarded Masimo $634 million in damages: “We are pleased by this outcome, and appreciate the time and attention given to our case by the court and the jury. This is a significant win in our ongoing...

Masimo Completes Sale of Consumer Audio Business to HARMAN International

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced it has completed the previously announced sale of its Sound United consumer audio business to HARMAN International (“HARMAN”), a wholly-owned subsidiary of Samsung Electronics Co., Ltd. Katie Szyman, Chief Executive Officer of Masimo, stated, “The completion of the Sound United sale is an important milestone in our ongoing efforts to focus on our core professional healthcare business. With this chapter behind us, we are even...

Masimo Announces Expansion of Strategic Partnership with Philips

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA). Building on over two decades of collaboration, this significant partnership expansion is designed to accelerate the integration of Masimo’s monitoring technologies, such as industry-leading SET® pulse oximetry, into a variety of Philips multi-parameter patient monitors through 2026 and beyond. This includes integrating...
Back to Newsroom